ACTINOGEN MEDICAL LIMITEDACTINOGEN MEDICAL LIMITEDACTINOGEN MEDICAL LIMITED

ACTINOGEN MEDICAL LIMITED

No trades
See on Supercharts
Market capitalization
‪69.81 M‬AUD
−0.007AUD
‪−10.75 M‬AUD
‪1.98 B‬
Beta (1Y)
1.74

About ACTINOGEN MEDICAL LIMITED

CEO
Steven G. Gourlay
Headquarters
Sydney
Founded
1999
ISIN
AU000000ACW3
FIGI
BBG000PS5K82
Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments or cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol. The company was founded by Geoff E. D. Brooke & David Keast on March 23, 1999 and is headquartered in Sydney, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ACW is 0.029 AUD — it has decreased by 3.33% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange ACTINOGEN MEDICAL LIMITED stocks are traded under the ticker ACW.
ACTINOGEN MEDICAL LIMITED is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
ACW stock is 7.14% volatile and has beta coefficient of 1.74. Check out the list of the most volatile stocks — is ACTINOGEN MEDICAL LIMITED there?
Yes, you can track ACTINOGEN MEDICAL LIMITED financials in yearly and quarterly reports right on TradingView.
ACW stock has fallen by 3.33% compared to the previous week, the month change is a 9.37% fall, over the last year ACTINOGEN MEDICAL LIMITED has showed a 52.08% decrease.
ACW net income for the last quarter is ‪−11.56 M‬ AUD, while the quarter before that showed ‪−3.31 M‬ AUD of net income which accounts for −248.77% change. Track more ACTINOGEN MEDICAL LIMITED financial stats to get the full picture.
Today ACTINOGEN MEDICAL LIMITED has the market capitalization of ‪69.81 M‬, it has decreased by 6.63% over the last week.
No, ACW doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ACW shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ACTINOGEN MEDICAL LIMITED stock right from TradingView charts — choose your broker and connect to your account.
ACW reached its all-time high on Oct 16, 2007 with the price of 0.854 AUD, and its all-time low was 0.007 AUD and was reached on Sep 6, 2019.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ACTINOGEN MEDICAL LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ACTINOGEN MEDICAL LIMITED stock shows the sell signal. See more of ACTINOGEN MEDICAL LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.